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INTRODUCTION  
Colorectal cancer manifests as cancerous growths in the 
colon, rectum and appendix. Colorectal cancer is the 
second most common cancer killer overall and third most 
common cause of cancer-related death in the United 
States in both males and females.1 Oral colon-specific 
drug delivery system (CDDS) is more advantageous over 
conventional cancer chemotherapy as it is ineffective in 
delivering drugs to the colon due to absorption or 
degradation of the active ingredient in the upper 
gastrointestinal tract.2 CDDS as an effective and safe 
therapy for colon cancer provides therapeutic 
concentrations of anticancer agent at the site of action 
and spare the normal tissues, with reduced dose and 
reduced duration of therapy.3 The successful targeted 
delivery of drug to the colon via the gastrointestinal tract 
(GIT) requires the protection of a drug from degradation 
and release in the stomach and small intestine and then 
ensures abrupt or controlled release in the proximal 
colon.4 
Capecitabine is an orally-administered chemotherapeutic 
agent used in the treatment of colorectal cancer and 
metastatic breast cancer. Capecitabine is a prodrug that is 
enzymatically converted to fluorouracil (antimetabolite) 
in the tumor, where it inhibits DNA synthesis and slows 
growth of tumor tissuesince it is readily absorbed from 
the gastrointestinal tract. The recommended daily dose is 
large, i.e., 2.5 g/m2 and it have a short elimination half-
life of 0.5–1 h5.  Varieties of approaches have been used 
and systems have been developed for the purpose of 
achieving colon targeting. These approaches are either 
drug-specific (prodrugs) or formulation-specific (coated 
or matrix preparations). The most commonly used 
targeting mechanisms are pH-dependent delivery; time-
dependent delivery; pressure-dependent delivery; and 
bacteria-dependent delivery.6  
The pH-dependent approach is based on the pH gradient 
of GIT that increases progressively from the stomach 
(pH 1.5-3.5) and small intestine (pH 5.5-6.8) to the colon 
(6.4-7.0). The most commonly used pH-dependent 
polymers are derivatives of acrylic acid and cellulose. By 
combining the knowledge of polymers and their 
solubility at different pH environments, delivery systems 
have been designed to deliver drugs at the target site. 
Most commonly used pH-dependent polymers are 
methacrylic acid copolymer (i.e., Eudragit L100 and 
Eudragit S100), which dissolve at pH 6.0, and 7.0, 
respectively. 7, 8 These polymers do not dissolve in 
stomach and intestinal pH due to hydrogen bonding 
between the hydroxyl groups of the carboxylic moiety 
and the carbonyl oxygen of ester groups in the polymer 
molecules. However, they dissolves in the colon because 
of the ionization of their carboxyl functional groups and 
releases the drug in the colon.9 It is possible to modify 
the polymer characteristics, by using the combination of 
Eudragit S100 and L100 in varying ratio.10 The addition 
of Eudragit L100 to Eudragit S100 in varying ratios 
altered the pH at which the polymer solubilised to 
produce formulations with high accuracy.     
The objective of the present investigation was to 
formulate and characterise the microspheres of 
capecitabine using pH sensitive polymers Eudragit S 100 
and L 100 separately and in combination for colon 
targeting. 
 
 
ABSTRACT 
The aim of the present work was to prepare the colon-targeting microspheres of capecitabine (CPB) for the treatment of 
colorectal cancer to reduce dosing frequency and improve patient compliance. PH-sensitive polymer Eudragit L100, S100 
separately and in combination (1:2) was used to formulate the microspheres by emulsion solvent diffusion technique using 
varying drug – polymer ratios (1:2 to 1:6). Microspheres were evaluated for particle size, shape, flow properties, surface 
morphology by scanning electron microscopy, yield, drug content, and in vitro drug release behavior and found to be 
significantly affected by polymer concentration. The formulated microspheres were discrete, spherical with relatively smooth 
surface, and with good flow properties. CPB-loaded microspheres demonstrated good entrapment efficiency (53.28 to 
93.76%). The release study was done in simulated gastrointestinal fluids for 2 hrs in SGF (pH 1.2), for 3 hrs in SIF (pH 6.8) 
and up to 24 hrs in SCF (pH 7.4) and  have shown that the drug was protected from being released in the physiological 
environment of the stomach and small intestine and efficiently released in colon (99.39%). Formulation ELS2 gave the best 
result among all formulations (1.59% release at end of 2 hrs, 19.24% at the end of 5 hr, and 99.39% at the end of the study). It 
is concluded from the present study that pH sensitive Eudragit microspheres are promising carriers for oral colon-targeted 
delivery of CPB for colorectal cancer. 
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MATERIALS AND METHODS 
The capecitabine was a kind gift from Cipla Laboratories 
Ltd (Mumbai, India). Eudragit S100 and L 100 were 
procured as a gift sample from Evonik Degussa India 
Pvt. Ltd., Mumbai, India. Tween 80 and 
dichloromethane were purchased from Central Drug 
House (P) Ltd. New Delhi. All other chemicals and 
reagents used in the study were of analytical grade. 
Preparation of Capecitabine Loaded pH Sensitive 
Microspheres11, 12 
Microspheres were prepared by a method based on the 
o/w emulsification-solvent evaporation technique using 
two polymers i.e. Eudragit L 100 and Eudragit S 100 
reported by Lamprecht et al with some modifications. 
Polymers were used separately and in combination (1:2 
respectively) to prepare microspheres.  
To prepare microspheres polymer and capecitabine were 
dissolved in 5 ml DCM (organic solvent) and 
ultrasonicated for 5 minutes. The resultant solution was 
dispersed drop-wise in aqueous medium containing 0.1% 
w/v Tween 80 (stabilizer), while stirring at 700 rpm 
using mechanical stirrer. This system was maintained 
under mechanical agitation at room temperature for 45 
minutes to allow the complete solvent evaporation. The 
microspheres were decanted, filtered and washed with 
distilled water for 3 times. The microspheres were air 
dried and kept in an airtight desiccator for further 
studies. All the formulation were prepared varying drug 
to polymer ratio (1:2, 1:3, 1:4, 1:5 and 1:6) using both 
the polymers Eudragit L100 and S100 separately and in 
combination. . The detailed Parameters for all the 
preparations are summarized in Table 1. 
 
Table: 1. Formulation Details of pH Sensitive Microspheres 
Polymer(mg) Formulation 
Code 
 
CPB  
(mg) 
 
Eudragit L 
100 
Eudragit L 
100 
Drug : 
polymer 
DCM 
(ml) 
 
EL1 100 200 - 1:2        5 
EL2 100 300 - 1:3 5 
EL3 100 400 - 1:4 5 
EL4 100 500 - 1:5 5 
EL5 100 600 - 1:6 5 
ES1 100 - 200 1:2 5 
ES2 100 - 300 1:3 5 
ES3 100 - 400 1:4 5 
ES4 100 - 500 1:5 5 
ES5 100 - 600 1:6 5 
ELS1 100 67 133 1:2 5 
ELS2 100 100 200 1:3 5 
ELS3 100 133 267 1:4 5 
ELS4 100 167 333 1:5 5 
ELS5 100 200 400 1:6 5 
 
Percentage yield13 
The prepared microspheres were collected and weighted. 
The actual weight of obtained microspheres divided by 
the total amount of all material that was used for the 
preparation of the microspheres using following 
equation: 
 
Characterization of the Microspheres 
Particle size of microspheres 
The particle size of the microspheres was determined by 
using optical microscopy method.13  
A small amount of dry microspheres was suspended in 
distilled water. A small drop of suspension was placed 
on a clean glass slide. The slide containing suspended 
microspheres was mounted on the stage of the 
microscope and 300 particles were measured using a 
calibrated ocular micrometer. The process was repeated 
three times for each batch prepared. 
Morphology                           
Shape and surface morphology was studied with 
projection microscope and photographs were taken and 
the selected formulations were further investigated using 
Environmental Scanning Electron Microscopy (ESEM, 
XL30, Philips, Netherlands). The samples were 
randomly scanned and photomicrographs were taken 
with ESEM.  
Flow Properties13 
The flow properties of microspheres were investigated 
by determining the angle of repose, bulk density, tapped 
density, Carr’s and Hausner’s ratio. Each parameter was 
calculated three times for each batch prepared and results 
were averaged. 
(i) Angle of Repose 
Angle of repose (θ) was measured according to the fixed 
funnel of Banker and Anderson. A funnel with the end of 
the stem cut perpendicular to the axis of symmetry is 
secured with its tip at a given height of 1cm (H), above 
graph paper placed on a flat horizontal surface. The 
microspheres were carefully poured through the funnel 
until the apex of the conical pile so formed just reached 
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the tip of the funnel. Thus, the R being the radius of the 
base of the microspheres conical pile: 
tan θ =   
 = tan-1  
Where,  = Angle of repose 
           H = Height of pile  
           R = Radius of pile. 
(ii) Carr’s Index and Hausner’s Ratio 
Poured density was determined by placing exact quantity 
'M ' of microsphere into a graduated cylinder and 
measuring the volume' V ' occupied by the microspheres.  
 
Tapped density was determined by placing a graduated 
cylinder containing a known quantity (M) of the 
prepared microspheres on a mechanical tapping 
apparatus, which was operated for a fixed number of taps 
until the bed volume reached to a minimum. 
 
The Carr’s Index and Hausner’s ratio were calculated 
using formula: 
Carr`s index (%) =   
                                  
Hausner’s ratio =   
 
Percentage drug entrapment 
To determine the drug entrapment, an accurately 
weighed amount (100 mg) of microspheres was 
dispersed in 100 mL of PBS (pH 7.4) in volumetric flask 
and shaken vigorously for 24 hrs using rotary shaker. 
Supernatant was filtered using a Whattman filter (0.45-
µm pore size) and analyzed for drug content by 
measuring absorbance in UV-spectrophotometer 
(ShimadzuUV-1800, Japan) at 239.6 nm.  
The drug content of each sample was determined in 
triplicate, and results were averaged. Drug entrapment 
efficiency was calculated by using the following 
formula: 13  
                              
 
 
In Vitro Drug Release Studies15, 16 
The in vitro drug release study of colon targeting CPB 
loaded microspheres was carried out in pH progression 
medium. The pH progression medium was attained by 
using simulated gastrointestinal fluids i.e. SGF, SIF, SCF 
pH in sequence, to mimic mouth-to-colon transit. 
Simulated gastric fluid (SGF) pH 1.2 consisted of NaCl 
(2.0 g), 0.1N HCl (7 mL), simulated intestinal fluid (SIF) 
of pH 6.8 consisted of Na2HPO4 (28.80 gm), KH2PO4 
(11.45 gm), simulated colonic fluid (SCF) of pH 7.4 
consisted of KH2PO4 (6.8 g), 0.2N NaOH (190 mL) in 
1000 mL distilled water. For first 2 hours, the dissolution 
study was conducted in SGF (pH 1.2) as the average 
gastric emptying time is about 2h. Then the dissolution 
medium was replaced with SIF (pH 6.8) study was 
continued for next 3 hours as the average small intestinal 
transit time is about 3h. After 5 hours, the dissolution 
medium was replaced with SCF (pH 7.4) and the study 
was continued till the end of release study. 
The drug dissolution test of microspheres was performed 
by the paddle method using USP XXIII paddle type 
dissolution apparatus (TDT-08L, Electro lab India, 
Mumbai) at 100 rpm and 37°C ± 0.5°C. Microspheres 
(100 mg) were weighed accurately and filled in tea bags. 
The tea bags were tied using thread with paddle and 
loaded into the basket of dissolution apparatus containing 
900mL of dissolution medium. The samples (5mL) were 
withdrawn from the dissolution medium at time interval 
of 1 hr using a pipette fitted with a microfilter at its tips 
and analyzed for drug by UV spectrophotometer against 
a standard curve(R2 > 0.99) obtained at λ = 239.60 nm. 
Perfect sink condition was maintained during the drug 
dissolution study period with the addition of an equal 
volume of fresh release medium at the same temperature. 
All the readings were taken in triplicate and results were 
averaged. 
In order to determine the mechanism & kinetics of drug 
release from the microspheres and to compare the release 
profile various formulations, the in-vitro release data 
were fitted to mathematical models. The kinetic models 
included zero order, first order, Higuch and Korsmeyer-
Peppas model. 
 
RESULTS AND DISCUSSION  
Preparation of Capecitabine Loaded pH sensitive 
Microspheres 
PH sensitive microspheres of capecitabine were 
successfully prepared by o/w emulsification-solvent 
evaporation technique. This method is used for 
microsphere preparation because of its simplicity, 
reproducibility, and fast processing with minimum 
controllable process variables that can be easily 
implemented at the industrial level.11 Eudragit L100, 
Eudragit S100 and their combination (1:2) were used to 
prepare pH sensitive microspheres. Eudragit L100 and 
Eudragit S100 dissolve at pH 6.0, and 7.0, respectively. 
These polymers do not dissolve at stomach and intestinal 
pH but dissolve in the colon and release the drug in the 
colon.  It was evident that the pH in the proximal colon 
ranges from 6.6 to 7.0 and then reaches up to neutral in 
distal colon. Therefore, The Eudragit L-100 and S-100 
were combined in different ratios and solubility of these 
combinations was checked in different pH solutions. 
From the solubility parameters, it was found that 
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Eudragit L-100 and S-100 in the ratios 1:2 was soluble in 
pH range of 6.6–7.0.17 Hence, this combination was 
selected for preparation of microspheres. DCM was used 
as organic solvent as it is an effective solvent for the 
polymer (Eudragit S100 and L 100) and drug at each of 
its selected levels. Tween 80 was used as stabilizer and 
necessary for microsphere formation with superior 
topographical characteristics. 
The percentage yield of different formulations was 
calculated and the results were shown in Table: 2 the 
yield was found in the range of 89.45% to 97.67% for all 
the formulations (EL1 to ELS5). The results indicated 
that the method o/w emulsification-solvent evaporation 
yields better percentage of CPB microspheres. 
As shown in Table: 2 the results demonstrated that 
drug/polymer ratios affected the microshperes 
characteristics while keeping the other variables 
constant. Particle size analysis of capecitabine 
microspheres showed that the mean microsphere 
diameter was affected by drug/polymer ratio. The mean 
diameter of all the formulations of pH sensitive polymers 
varied from 84.58±7.29 µm to 124.41±9.25µm with 
varying drug/polymer ratio. The average particle size of 
microspheres increased with increasing polymer 
concentration, as higher concentration of polymer 
produced a more viscous dispersion, which formed larger 
droplets and consequently larger microspheres were 
formed.
 
Table 2: Physical Characteristics of pH Sensitive Microspheres 
Serial no. Formulation code Average Particle 
Size (µm) 
Yield 
(%) 
Entrapment 
Efficiency (%) 
1. EL1 103.42±7.31 89.45 75.52 
2. EL2 107.51±5.52 92.08 76.21 
3. EL3 110.64±.8.23 94.78 80.65 
4. EL4 117.24±4.42 95.50 82.32 
5. EL5 124.41±9.25 96.45                                                                   83.46
6. ES1 95.20±6.12 87.46 53.28 
7. ES2 101.54±8.11 88.24 68.06 
8. ES3 107.10±4.21 93.51 70.09 
9. ES4 114.56±10.14 97.67 72.64 
10. ES5 119.02±8.12 94.36 72.03 
11. ELS1 84.58±7.29 95.50 84.01 
12. ELS2 99.74±12.74 90.78 86.88 
13. ELS3 102.97±7.65 97.25 89.81 
14. ELS4 105.75±6.41 94.48 93.76 
15. ELS5 109.32±4.54 95.64 91.93 
Results shown are average of three readings ±SD,(n=3) 
 Table 3: Flow Properties of pH Sensitive Microspheres 
  Serial no. Formulation 
code 
Angle of 
Repose   (°) 
Bulk Density 
(gm/cm3) 
Tapped 
Density 
(gm/cm3) 
     Carr’s 
Index 
(%) 
Hausner’s 
Ratio 
1. EL1 25.45±1.15 0.219±0.017 0.253±0.008 13.44 1.16 
2. EL2 24.30±1.01 0.315±0.014 0.363±0.007 13.22 1.15 
3. EL3 24.10±0.75 0.247±0.012 0.289±0.006 14.53 1.17 
4. EL4 22.80±0.52 0.224±0.015 0.271±0.006 17.34 1.21 
5. EL5 18.92±0.74 0.297±0.014 0.357±0.007 16.81 1.20 
6. ES1 24.25±0.63 0.314±0.009 0.364±0.008 13.74 1.16 
7. ES2 23.70±0.42 0.278±0.011 0.327±0.005 14.98 1.18 
8. ES3 21.55±1.35 0.303±0.013 0.368±0.007 17.66 1.21 
9. ES4 20.83±0.79 0.329±0.011 0.391±0.006 15.86 1.19 
10. ES5 19.34±0.88 0.352±0.014 0.412±0.004 14.56 1.17 
11. ELS1 24.41±1.45 0.249±0.020 0.293±0.008 15.02 1.18 
12. ELS2 22.60±0.64 0.226±0.018 0.264±0.006 14.39 1.17 
13. ELS3 22.32±1.34 0.256±0.010 0.287±0.007 10.80 1.12 
14. ELS4 20.50±0.42 0.283±0.015 0.329±0.006 13.98 1.16 
15. ELS5 20.22±1.16 0.197±0.013 0.225±0.004 12.44 1.14 
Results shown are average of three readings ±SD,(n=3) 
It can be clearly observed from the photographs (Fig.4) 
of the microspheres prepared by solvent evaporation 
technique, that the microspheres are small, spherical and 
discrete. The shape and surface morphology was further 
confirmed with the SEM photograph (Fig.5). The 
microspheres were spherical and have almost smooth 
surface. 
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The values of angles of repose were in the range of 
18.92° ± 0.74 to 25.45° ± 1.15, the values of Carr’s index 
were in the range of 10.80% to 17.66% and the values of 
Hausner ratio were ranged from 1.12 to 1.21 for all the 
formulations (Table 3). Comparison of calculated results 
with standard values indicates an overall good free 
flowing nature of microspheres of all batches. Values of 
angle of repose ≤ 30° usually indicate a free flowing 
material, while values of compressibility index below 20 
% give rise to good flow characteristics. 
Percent entrapment efficiency of the formulations was 
found in the range of 53.28% to 93.76 in all the 
formulations given in Table:2. All the formulations show 
good entrapment efficiency. The entrapment efficiency 
of Eudragit L100 microspheres was found better than 
that of Eudragit S100 microspheres. But it was found 
excellent for the formulations prepared with the 
combinations of these two polymers. Overall a similar 
pattern was found in three categories (EL1-EL5, ES1-
ES5 and ELS1-ELS5) that the percentage entrapment 
increased by increasing the polymer ratio. It was reported 
in the literature that the encapsulation efficiency depends 
on the solubility of the drug in the solvent and 
continuous phase. An increase in the concentration of 
polymer in a fixed volume of organic solvent resulted in 
an increase in encapsulation efficiency.17 Hence 
capecitabine being aqueous soluble drug required high 
concentration of polymer in dosage form for better 
formulation development. 
In vitro drug release study of pH dependent CPB 
microspheres was performed in pH progression medium  
and the in vitro drug release data of CPB in simulated 
gastrointestinal fluids (SGF, SIF and SCF) for all the 
formulations are given in Fig:1 to Fig: 3. The drug 
release was found to be 1.97 to 10.97% for EL1 to EL5, 
1.81 to 5.53% for ES1 to ES5 and 0.84 to2.98% for 
ELS1 to ELS5 at the end of 2 hrs in SGF (pH 1.2). In 
SIF (pH 6.8) for next 3 hrs, the drug release was found in 
the range of 39.24 to 67.88% for EL1 to EL5, 6.08 to 
9.45% for ES1 to ES5 and 7.09 to 25.89% for ELS1 to 
ELS5 at the end of 5 hrs. At the end of the study (24 hrs) 
the cumulative drug release was found to be 89.73 to 
98.29% for EL1 to EL5, 71.91 to 92.13% for ES1 to ES5 
and 84.55 to 99.39% for ELS1 to ELS5. The result 
shows that the cumulative drug release deceased as the 
polymer concentration increased. It may be due to the 
fact that the increase in polymer concentration increases 
the density of polymer matrix and the diffusion path 
length that the drug has to traverse. 
 
 
Results shown are average of three readings ±SD,(n=3) 
Figure 1:    Zero order plots for Release Profile of Formulations EL1 to EL5 
 
Figure 2:   Zero order plots for Release Profile of Formulations ES1 to ES5 
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Results shown are average of three readings ±SD,(n=3) 
Figure 3:  Zero order plots for Release Profile of Formulations ELS1 to ELS5 
It is observed that all the formulations gave the drug 
release less than 6±5% in first two hrs in SGF (pH 1.2) 
and this may be due to initial dissolution of drug 
particles adsorbed at the surface. Hence, all the 
formulations can prevent the drug from being released in 
the physiological environment of the stomach. 
Formulations EL1 to EL5 released 50±15% of drug in 
SIF (pH 6.8) and rest of the drug was released in SCF 
(pH7.4), as the polymer Eudragit L100 get dissolved at 
pH 6.0. Formulations ES1 to ES5 gave only 8±2% of the 
drug release in SIF may be due to swelling of polymer 
and significant drug release was observed in SCF (pH 
7.4). These formulations of Eudragit S 100 did not 
release complete drug in SCF. ELS1 to ELS5 released 
16±7% drug in SIF due to faster solubilisation of 
Eudragit L 100 than Eudragit S100 at the pH 6.8, 
because L100 polymer is soluble at pH 6.0. These 
formulations delivered their drug load in a controlled 
manner in SCF and gave the maximum drug release at 
the end of the study as compare to ES1 to ES5. 
Overall the formulation ELS2 showed more promising 
results amongst all the formulations (1.59% release at 
end of 2 hrs, 19.24% at the end of 5 hr, and 99.39% at 
the end of the study). 
Drug release mechanisms were determined by fitting in 
vitro drug release data to various kinetic models. The 
kinetic model showing highest regression coefficient was 
considered as the most appropriate model for the 
dissolution data. By comparing regression values (R2) for 
Zero order, First order, Higuchi model, and Korsmeyer–
Peppas model, it is concluded that all formulations gave 
good fit to the Korsmeyer–Peppas model. The diffusion 
exponent (n) values were found to be greater than 1, so 
the drug release follows super case II transport. This 
model will help to analyze the release of formulations, 
when the release mechanism is not well known or when 
more than one type of release phenomenon could be 
involved.19
Table 4: Kinetic Parameters of pH sensitive microspheres of Different Models 
Zero Order First Order Higuchi Korsmeyer-Peppas 
Formulation K  
(mg/h) 
R2 K (h–1) R2 K (mg/h1/2)     R2 R2 n 
EL1 5.0012 0.696 -0.094 0.8382 27.993 0.8206 0.9001 1.5703 
EL2 5.0126 0.6997 -0.0979 0.8368 28.022 0.823 0.9011 1.5638 
EL3 4.9618 0.6917 -0.0979 0.8153 27.744 0.814 0.9015 1.5866 
EL4 4.8093 0.699 -0.0618 0.7964 26.716 0.8119 0.9021 1.6647 
EL5 4.6327 0.7286 -0.0515 0.8053 25.304 0.8181 0.9067 1.6549 
ES1 4.8545 0.748 -0.0573 0.8123 25.466 0.7748 0.9045 1.4848 
ES2 4.8144 0.746 -0.0549 0.8001 25.203 0.7695 0.9031 1.4798 
ES3 4.5274 0.7475 -0.0436 0.7969 23.607 0.7649 0.9043 1.5228 
ES4 4.1549 0.741 -0.0346 0.7814 21.719 0.7621 0.9011 1.5874 
ES5 3.8531 0.7456 -0.0294 0.7758 19.981 0.7547 0.91 1.5798 
ELS1 4.9931 0.7172 -0.0803 0.7958 27.414 0.8137 0.9015 1.5771 
ELS2 5.1906 0.7187 -0.0974 0.8214 28.104 0.793 0.9024 1.7247 
ELS3 4.9671 0.7251 -0.0636 0.791 26.653 0.7858 0.9065 1.731 
ELS4 4.8018 0.7338 -0.0524 0.7995 25.449 0.7757 0.904 1.8315 
ELS5 4.5596 0.7492 -0.0428 0.8022 23.649 0.7586 0.9049 1.8633 
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                                      (a) 
 
 
                                   (b) 
   
 
 
(a)              (b)        (c) 
Figure 4: (a) Photograph of microspheres (EL2)  (b)Photograph of microspheres (ES3) (c) Photograph of 
microspheres (ELS3) 
 
 
Figure 5: Sem photograph of microspheres (ELS2) 
 
CONCLUSION 
In this study, colon targeted microspheres of anticancer 
drug Capecitabine were formulated successfully using 
pH sensitive polymers Eudragit L100, S100 separately 
and in combination (1:2) for colonic delivery of drug. 
Spherical and free-flowing microspheres were prepared 
by emulsion solvent evaporation method. The good 
flowability and packability of microspheres, indicates 
that they can be successfully handled and either filled 
into a capsule or compressed to tablet dosage form. All 
the formulations were found to be efficient with good 
recovery yield and percent drug entrapment. The study 
revealed that the release profile of microspheres was 
affected by polymer concentration and microspheres 
were capable to retard the release of CPB until it reaches 
the colon. This shows that pH sensitive colon targeting 
micro particulate drug delivery system can be used to 
treat the colorectal cancer by minimising the wastage of 
drug and undue toxic effect on the normal cells.   
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